AHA chief on research, health equity and more
Robert Harrington, the new president of the American Heart Association, recently discussed his views on technology and diversity in medicine.
Real-world data in the clinic
In an interview, computational biologist Tina Hernandez-Boussard discusses analyzing the value of electronic health records as a source of information in the clinic.
Dennis Wall on new discoveries in autism genetics
Wall discusses how he and his collaborators used whole-genome data from hundreds of families affected by autism to identify 16 new autism risk genes and a rare genetic syndrome that explains some cases of the disorder.
Increasing diversity in genome studies
Data scientist Genevieve Wojcik speaks about the lack of diversity in genomewide association studies, why it’s a problem and how increasing diversity in these studies can elevate the entire population.
Using RNA for rare-disease diagnosis
Geneticist Stephen Montgomery explains why the transcriptome, the collection of RNA molecules in a cell, is a crucial piece of deciphering the source of rare diseases.
Building new hospital to withstand quakes
Bert Hurlbut, vice president of new hospital construction at Stanford Health Care, discussed the strategies his team used to make the new Stanford Hospital earthquake-resistant.
Stanford aids fight against antibiotic resistance
A Stanford program has been designated as a collaborating center to help the World Health Organization combat the overuse and misuse of antibiotics.
Schatzberg urges caution with ketamine
Physicians and patients are excited about ketamine, the latest drug to treat depression, but Stanford psychiatrist Alan Schatzberg says we need to tread carefully.
Potential and perils of AI
Stanford primary care specialist Steven Lin asserts that artificial intelligence, if deployed properly, can reduce physicians’ administrative workload and support them in providing caring, personalized medicine.
Quashing myths about PTSD
Shaili Jain, a Stanford psychiatrist, discusses the explosion of knowledge about post-traumatic stress disorder and the condition’s widespread impact. PTSD is the subject of her new book, The Unspeakable Mind.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.